203 related articles for article (PubMed ID: 32348468)
21. Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes.
Xu S; Huang H; Qian J; Liu Y; Huang Y; Wang X; Liu S; Xu Z; Liu J
JAMA Netw Open; 2021 Jul; 4(7):e2118526. PubMed ID: 34313737
[TBL] [Abstract][Full Text] [Related]
22. Epitope-Specific Antitumor Immunity Suppresses Tumor Spread in Papillary Thyroid Cancer.
Ehlers M; Kuebart A; Hautzel H; Enczmann J; Reis AC; Haase M; Allelein S; Dringenberg T; Schmid C; Schott M
J Clin Endocrinol Metab; 2017 Jul; 102(7):2154-2161. PubMed ID: 27860539
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of the human major histocompatibility complex class I chain-related gene A (MICA) and its receptor is mediated by microRNA-146b-5p and is a potential mechanism of immunoediting in papillary thyroid carcinoma.
Al-Abdallah A; Jahanbani I; Mehdawi H; Ali RH; Al-Brahim N; Mojiminiyi O; Junaid TA
Exp Mol Pathol; 2020 Apr; 113():104379. PubMed ID: 31935378
[TBL] [Abstract][Full Text] [Related]
24. Chronic Lymphocytic Thyroiditis with Oncocytic Metaplasia Influences PD-L1 Expression in Papillary Thyroid Carcinoma.
Santana VB; Krüger VM; Abrahão MCY; Cantú PLM; Brackmann RL; Pandolfi GM; Marisco LS; Remonatto G; Ferreira LA; Graudenz MS
Head Neck Pathol; 2024 Mar; 18(1):14. PubMed ID: 38457034
[TBL] [Abstract][Full Text] [Related]
25. The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study.
Nasiri S; Yazd SMM; Gholami M; Shahriarirad S; Sharghi S; Shahriarirad R
BMC Endocr Disord; 2023 Mar; 23(1):66. PubMed ID: 36964545
[TBL] [Abstract][Full Text] [Related]
26. Identification of
Zhang Y; Xie X; Zhou H; Li B; Ding L; Cai Z; Song H; Zhao S; Xu H
Front Endocrinol (Lausanne); 2023; 14():1131078. PubMed ID: 37455914
[TBL] [Abstract][Full Text] [Related]
27. EV PD-L1 is Correlated With Clinical Features and Contributes to T Cell Suppression in Pediatric Thyroid Cancer.
Wang G; He L; Wang S; Zhang M; Li Y; Liu Q; Sun N; Zhang X; Liu Y; Zhang J; Tai J; Ni X
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32459310
[TBL] [Abstract][Full Text] [Related]
28. Thyroid cancer associated with Hashimoto thyroiditis: similarities and differences in an endemic area.
Hussein O; Abdelwahab K; Hamdy O; Awny S; Megahed NA; Hafez MT; Elalfi AF; Abdelaziz M; Gaballah K; Abdelkhalek M
J Egypt Natl Canc Inst; 2020 Jan; 32(1):7. PubMed ID: 32372240
[TBL] [Abstract][Full Text] [Related]
29. Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis.
Yi JW; Park JY; Sung JY; Kwak SH; Yu J; Chang JH; Kim JH; Ha SY; Paik EK; Lee WS; Kim SJ; Lee KE; Kim JH
Endocr J; 2015; 62(10):857-77. PubMed ID: 26211532
[TBL] [Abstract][Full Text] [Related]
30. Papillary thyroid cancer with Hashimoto's thyroiditis attenuates the tumour aggressiveness through the up-regulation of E-cadherin and TGF-β expression.
Kim SJ; Lee SE; Kim YI; Nam-Goong IS; Jung HW; Kim ES
Clin Exp Med; 2023 Jul; 23(3):833-840. PubMed ID: 35871446
[TBL] [Abstract][Full Text] [Related]
31. Interaction of BANCR in the relationship between Hashimoto's thyroiditis and papillary thyroid carcinoma expression patterns and possible molecular mechanisms.
Zhang J; Yao L; Guo Y
J Gene Med; 2024 Feb; 26(2):e3663. PubMed ID: 38342961
[TBL] [Abstract][Full Text] [Related]
32. Genetic alterations in papillary thyroid carcinoma and hashimoto thyroiditis: An analysis of hOGG1 loss of heterozygosity.
Royer MC; Zhang H; Fan CY; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2010 Mar; 136(3):240-2. PubMed ID: 20231640
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment.
Sulaieva O; Chernenko O; Selesnov O; Nechay O; Maievskyi O; Falalyeyeva T; Kobyliak N; Tsyryuk O; Penchuk Y; Shapochka D
Endocrinol Metab (Seoul); 2020 Jun; 35(2):443-455. PubMed ID: 32615729
[TBL] [Abstract][Full Text] [Related]
34. Frequency of hashimoto thyroiditis in papillary thyroid cancer patients and its impact on their Outcome.
Batool S; Das B; Arif M; Islam N
J Ayub Med Coll Abbottabad; 2022; 34(2):251-255. PubMed ID: 35576281
[TBL] [Abstract][Full Text] [Related]
35. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis.
Kim SK; Song KH; Lim SD; Lim YC; Yoo YB; Kim JS; Hwang TS
Thyroid; 2009 Feb; 19(2):137-41. PubMed ID: 19014278
[TBL] [Abstract][Full Text] [Related]
36. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.
Zhang Y; Dai J; Wu T; Yang N; Yin Z
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1021-6. PubMed ID: 24619663
[TBL] [Abstract][Full Text] [Related]
37. Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.
Marotta V; Sciammarella C; Chiofalo MG; Gambardella C; Bellevicine C; Grasso M; Conzo G; Docimo G; Botti G; Losito S; Troncone G; De Palma M; Giacomelli L; Pezzullo L; Colao A; Faggiano A
Endocr Relat Cancer; 2017 Sep; 24(9):485-493. PubMed ID: 28696209
[TBL] [Abstract][Full Text] [Related]
38. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?
Kwak HY; Chae BJ; Eom YH; Hong YR; Seo JB; Lee SH; Song BJ; Jung SS; Bae JS
Int J Clin Oncol; 2015 Jun; 20(3):463-73. PubMed ID: 25312294
[TBL] [Abstract][Full Text] [Related]
39. Association between Hashimoto's thyroiditis and papillary thyroid carcinoma: a retrospective analysis of 305 patients.
Graceffa G; Patrone R; Vieni S; Campanella S; Calamia S; Laise I; Conzo G; Latteri M; Cipolla C
BMC Endocr Disord; 2019 May; 19(Suppl 1):26. PubMed ID: 31142293
[TBL] [Abstract][Full Text] [Related]
40. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
